ArticleFrontiers in endocrinology2026
Dietary fibers to boost endogenous GLP-1 secretion and satiety: a scoping review.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Dietary fibers can stimulate endogenous glucagon-like peptide-1 (GLP-1) secretion through microbial fermentation and gut hormone signaling, potentially enhancing satiety and supporting weight management. Given the growing interest in non-pharmacological strategies to complement or support tapering of GLP-1 receptor agonist therapy, a structured overview of the human evidence is needed. Methods: A pre-registered scoping review was conducted using PubMed, Scopus and Cochrane Central. Randomized controlled trials in adults assessing circulating GLP-1 concentrations and satiety following supplementation with a single, well-defined dietary fiber were included. Fiber types were categorized based on structural characteristics. Outcomes were summarized qualitatively across fiber categories. Results: In total, 1049 papers were screened and 49 publications comprising 52 studies (total n=1,085 participants; median sample size per study=19) were included. Most studies were acute interventions (71%) and conducted in Western populations. Studies reporting increased GLP-1 showed a non-significant tendency to also report increased satiety (OR = 2.95, 95% CI: 0.87-9.98). Dextrins stood out as one of the few fiber categories showing robust effects on both GLP-1 (4 positive studies) and satiety (5 positive studies). Other fibers, such as β-glucans and mannans, showed more uniform effects on satiety or GLP-1, respectively, but did not consistently affect both outcomes simultaneously. Conclusions: Although these findings identify dextrins as a promising dietary fiber candidate for future research, the evidence remains constrained by small sample sizes, short interventions, and substantial heterogeneity. Longer-term studies in free-living conditions, including periods of GLP-1 receptor agonist tapering, are needed to capture microbiota adaptation and generate robust real-world evidence. Systematic review registration: https://osf.io/cnw4e/overview.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.